BioCatalystWatch
TTRXWorkspace / TTRX / OverviewCompany library
Turn Therapeutics Inc. logo

Turn Therapeutics Inc.

Turn Therapeutics Inc. (TTRX)

Website

Price
Market cap
Next catalystExpected Q4 2026GX-03 — adaptive Phase 2a/2b atopic dermatitis study · Study completionSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

GX-03

IL-36α × IL-36γ × IL-31 × IL-4

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

GX-03

IL-36α × IL-36γ × IL-31 × IL-4

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

GX-03

IL-36α × IL-36γ × IL-31 × IL-4

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

GX-03

IL-36α × IL-36γ × IL-31 × IL-4

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

GX-03

IL-36α × IL-36γ × IL-31 × IL-4

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

GX-03

IL-36α × IL-36γ × IL-31 × IL-4

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Other pipelines

GX-03

IL-36α × IL-36γ × IL-31 × IL-4

PreINDP1P2P3FilingApproved

Partner / License out

Approved / commercial

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Reported shares and borrowings

Shares outstanding

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TTRX PR & News

PR & News

TTRX SEC archive